Cell-penetrating peptide-mediated delivery of therapeutic peptides/proteins to manage the diseases involving oxidative stress, inflammatory response and apoptosis

J Pharm Pharmacol. 2022 Aug 19;74(8):1085-1116. doi: 10.1093/jpp/rgac038.

Abstract

Objectives: Peptides and proteins represent great potential for modulating various cellular processes including oxidative stress, inflammatory response, apoptosis and consequently the treatment of related diseases. However, their therapeutic effects are limited by their inability to cross cellular barriers. Cell-penetrating peptides (CPPs), which can transport cargoes into the cell, could resolve this issue, as would be discussed in this review.

Key findings: CPPs have been successfully exploited in vitro and in vivo for peptide/protein delivery to treat a wide range of diseases involving oxidative stress, inflammatory processes and apoptosis. Their in vivo applications are still limited due to some fundamental issues of CPPs, including nonspecificity, proteolytic instability, potential toxicity and immunogenicity.

Summary: Totally, CPPs could potentially help to manage the diseases involving oxidative stress, inflammatory response and apoptosis by delivering peptides/proteins that could selectively reach proper intracellular targets. More studies to overcome related CPP limitations and confirm the efficacy and safety of this strategy are needed before their clinical usage.

Keywords: Apoptosis; CPPs; Cell penetrating peptides; Drug delivery; Inflammatory response; Oxidative stress.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Cell-Penetrating Peptides* / metabolism
  • Drug Delivery Systems
  • Oxidative Stress
  • Proteins

Substances

  • Cell-Penetrating Peptides
  • Proteins